Studies on the expression of recombinant human MCAF/GM-CSF fusion protein and its biological activities

被引:0
|
作者
Ye, QN [1 ]
Su, GF [1 ]
Huang, OF [1 ]
机构
[1] INST BIOTECHNOL,BEIJING 100071,PEOPLES R CHINA
来源
ACTA BIOCHIMICA ET BIOPHYSICA SINICA | 1996年 / 28卷 / 02期
关键词
MCAF; GM-CSF; fusion protein; gene expression;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With PCR technology and methods of DNA recombination in vitro, the fusion protein of GM-CSF with MCAF, the factor that has a directing effect on cells to a target was generated by the construction of recombinant plasmids pMG01, pMG02 and pMG03 with different nucleotide composition between its SD sequence and the initiation codon ATG under the control of lambda PRPL promoter of vector pBV220. Although no stable secondary structure exist in the translation initiation regions of all the recombinant plasmid constructed, the expression lapels of the products with DH5 alpha (pMG02) and DH5 alpha (pMG03) are much higher than that with DH5 alpha (pMG01) which hardly expressed the product. The assay of Western blot indicated that the expressed product reacted with MCAF and GM-CSF antibodies, respectively. The assay of biological activities showed that the expressed product had apparent monocyte chemoattractant activity and supported the growth of the human human GM-CSF-dependent cell line TF1, suggesting that the biological functions of MCAF and GM-CSF are compatible.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 50 条
  • [41] EFFECTS OF RECOMBINANT HUMAN G-CSF AND GM-CSF ON PRIMARY HUMAN-LEUKEMIC CELLS
    ITOH, K
    BESSHO, M
    HIRASHIMA, K
    ACTA HAEMATOLOGICA JAPONICA, 1989, 52 (06): : 988 - 995
  • [42] EXVIVO INCUBATION OF HUMAN ALLOGENEIC DONOR MARROW WITH RECOMBINANT HUMAN GM-CSF PRIOR TO ITS INFUSION INTO THE RECIPIENT
    ATKINSON, K
    BARTLETT, A
    DODDS, A
    BIGGS, J
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 770 - 770
  • [43] Expression of the human GM-CSF receptor α subunit in Saccharomyces cerevisiae
    Tu, JL
    Golde, DW
    Vera, JC
    Heaney, ML
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1998, 4 (03) : 147 - 151
  • [44] ARMED NEONATAL PMNS FOLLOWING THE PRIMING OF RECOMBINANT HUMAN GM-CSF (RHGM-CSF)
    CAIRO, MS
    TOY, C
    MAUSS, D
    VANDEVEN, C
    SENDER, LS
    PEDIATRIC RESEARCH, 1989, 25 (04) : A268 - A268
  • [45] COUPLING OF THE HUMAN GM-CSF RECEPTOR TO BIOLOGICAL RESPONSES BY THE PROTOONCOGENE HCK
    LINNEKIN, D
    HOWARD, OMZ
    PARK, L
    FARRAR, W
    FERRIS, D
    LONGO, DL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 115 - 115
  • [46] AGE-DEPENDENT ALTERATIONS OF HUMAN RECOMBINANT GM-CSF EFFECTS ON HUMAN GRANULOCYTES
    SERES, I
    CSONGOR, J
    MOHACSI, A
    LEOVEY, A
    FULOP, T
    MECHANISMS OF AGEING AND DEVELOPMENT, 1993, 71 (1-2) : 143 - 154
  • [47] BIOLOGICAL-ACTIVITY OF RECOMBINANT GM-CSF IN SERUM-FREE CULTURES OF HUMAN SEMIPURIFIED PROGENITOR CELLS
    MIGLIACCIO, G
    MIGLIACCIO, AR
    CASSON, J
    GOLDE, D
    PESCHLE, C
    EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 489 - 489
  • [48] DIFFERENTIAL EXPRESSION OF M-CSF, G-CSF, AND GM-CSF BY HUMAN MONOCYTES
    LEE, MT
    KAUSHANSKY, K
    RALPH, P
    LADNER, MB
    JOURNAL OF LEUKOCYTE BIOLOGY, 1990, 47 (03) : 275 - 282
  • [49] RECOMBINANT HUMAN GM-CSF FOLLOWING CHEMOTHERAPY IN HIGH-RISK AML
    BUECHNER, T
    HIDDEMANN, W
    KOENIGSMANN, M
    ZUEHLSDORF, M
    WOERMANN, B
    BOECKMANN, A
    FREIRE, EA
    INNIG, G
    MASCHMEYER, G
    LUDWIG, WD
    SAUERLAND, CM
    SCHULZ, G
    BONE MARROW TRANSPLANTATION, 1990, 6 : 131 - 134
  • [50] PRECLINICAL SAFETY ASSESSMENT OF RECOMBINANT HUMAN GM-CSF IN RHESUS-MONKEYS
    ROBISON, RL
    MYERS, LA
    INTERNATIONAL REVIEW OF EXPERIMENTAL PATHOLOGY, 1993, 34 : 149 - 172